NVDA
NVIDIA
-- 140.110 RGTI
Rigetti Computing
-- 10.0400 TSLA
Tesla
-- 394.940 AMD
Advanced Micro Devices
-- 121.840 TSM
Taiwan Semiconductor
-- 207.120 
NEWS
Tonix Pharmaceuticals to Present at Two Upcoming January Investor Conferences
Tuesday, 7th January at 7:00 am
CHATHAM, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development candidates, announced today that Tonix management will present and host investor meetings at the following January investor conferences:
8th Annual Neuroscience Innovation Forum by Sachs Associates
Company Presentation
Presenter:Seth Lederman, M.D., President and Chief Executive Officer of Tonix PharmaceuticalsDate:Sunday, January 12, 2025Place:Marines Memorial Club, San Francisco, Calif.Time:11:15 a.m. PTRoom:Track A – Room Rosenberg
Panel
Participant:Seth Lederman, M.D., President and Chief Executive Officer of Tonix PharmaceuticalsTitle:Revolutionizing Neuropsychiatric Treatments: Novel Approaches PanelDate:Sunday, January 12, 2025Place:Marines Memorial Club, San Francisco, Calif.Time:1:15 p.m. PT
2025 Biotech Showcase
Presenter:Seth Lederman, M.D., President and Chief Executive Officer of Tonix PharmaceuticalsDate:Tuesday, January 14, 2025Place:Hilton San Francisco Union Square, San Francisco, Calif.Time:10:00 a.m. PTRoom:Yosemite C (Ballroom level)
Tuesday, 7th January at 7:00 am
CHATHAM, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development candidates, announced today that Tonix management will present and host investor meetings at the following January investor conferences:
8th Annual Neuroscience Innovation Forum by Sachs Associates
Company Presentation
Presenter:Seth Lederman, M.D., President and Chief Executive Officer of Tonix PharmaceuticalsDate:Sunday, January 12, 2025Place:Marines Memorial Club, San Francisco, Calif.Time:11:15 a.m. PTRoom:Track A – Room Rosenberg
Panel
Participant:Seth Lederman, M.D., President and Chief Executive Officer of Tonix PharmaceuticalsTitle:Revolutionizing Neuropsychiatric Treatments: Novel Approaches PanelDate:Sunday, January 12, 2025Place:Marines Memorial Club, San Francisco, Calif.Time:1:15 p.m. PT
2025 Biotech Showcase
Presenter:Seth Lederman, M.D., President and Chief Executive Officer of Tonix PharmaceuticalsDate:Tuesday, January 14, 2025Place:Hilton San Francisco Union Square, San Francisco, Calif.Time:10:00 a.m. PTRoom:Yosemite C (Ballroom level)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
6011Followers
70Following
64KVisitors
Follow
Discussing
Trump 2.0 countdown: What's the next big opportunity in the markets?
Trump is gearing up for a return to the political stage, and his "America First" tariff policies, along with his stance on cryptocurrency an
Michael McCarthy CCO
Jan 3 11:57
Ask a strategist - Trump's first day
NoNo444 : Interesting
In His GraceMercy : Updating milestones and also highlighting latest clinical data?